Lindsey Howell
Family · Southaven, MSNPI 1801429527
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 99.0% of the total across 598 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 60 manufacturers, the largest accounting for just 9.6% — the pattern of someone who eats at a lot of different presentations. Reporting peaked in 2022 at $5,088 and has fallen 79.7% since, to $1,035 in 2025. Among family clinicians in MS with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 598 payments — averaging $17.98 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$1K
- Novartis$1K
- AstraZeneca$844
- SK Life Science, Inc.$594
- Biohaven Pharmaceuticals, Inc.$570
- Biohaven Pharmaceutical Holding Company Ltd.$530
- plus $6K from 54 others
What the payments were for
- Speaking & faculty fees$1111%
- Food & beverage$10,64299%
- Education$10%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- UBRELVY$335
- NURTEC ODT$252
- VNS - Sentiva$136
- DUPIXENT$119
- AUSTEDO$117
- RYTARY$111
- BRILINTA$110
- KESIMPTA$104
How this compares
$10,754 in reported general payments places this provider in the 95th percentile of 3,007 family providers in Mississippi.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Levetiracetam | 11 | $470 |
| Divalproex Sodium | 11 | $264 |
Paid to pharmacies, not to this prescriber.
Other family in Southaven
- Lindsey GarnerSouthaven$16K
- Angela UgwuanyiSouthaven$13K
- Dodie McGeeRaymond$772K
- Gina BurgeJackson$237K
- Christy DavisJackson$208K
- Maranda EversollFlowood$197K
- Dana DelaskiJackson$158K
- Kristin CarrollJackson$158K
- Shannon FryeryOxford$127K
- Nativel CollinsMantachie$73K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.